These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15201952)

  • 1. The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse.
    Hulboy DL; Gautam S; Fingleton B; Matrisian LM
    Oncol Rep; 2004 Jul; 12(1):13-7. PubMed ID: 15201952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
    Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
    Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
    Lee J; Hargest R; Wasan H; Phillips RK
    Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
    Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
    Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
    Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(min)/+ mice.
    Moser AR; Hegge LF; Cardiff RD
    Cancer Res; 2001 Apr; 61(8):3480-5. PubMed ID: 11309311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
    Kettunen HL; Kettunen AS; Rautonen NE
    Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutational mechanisms involved in intestinal tumor formation in Min mice.
    Shoemaker AR; Luongo C; Moser AR; Marton LJ; Dove WF
    Cancer Res; 1997 May; 57(10):1999-2006. PubMed ID: 9157997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression pattern of four membrane-type matrix metalloproteinases in the normal and diseased mouse mammary gland.
    Szabova L; Yamada SS; Birkedal-Hansen H; Holmbeck K
    J Cell Physiol; 2005 Oct; 205(1):123-32. PubMed ID: 15895410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of modifiers of the ApcMin mutation in intestine and mammary gland.
    Czarnomska A; Krysiak E; Piskorowska J; Sitarz M; Pysniak K; Pilcík T; Demant P
    Cancer Res; 2003 Aug; 63(15):4533-7. PubMed ID: 12907628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.
    Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR
    Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1370):915-23. PubMed ID: 9684289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland.
    Prosperi JR; Becher KR; Willson TA; Collins MH; Witte DP; Goss KH
    J Cell Physiol; 2009 Aug; 220(2):319-31. PubMed ID: 19326388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
    Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
    Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
    Owen JL; Torroella-Kouri M; Iragavarapu-Charyulu V
    Int J Mol Med; 2008 Jan; 21(1):125-34. PubMed ID: 18097625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
    Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
    Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q; Ishikawa TO; Oshima M; Taketo MM
    Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling of murine intestinal adenomas reveals early deregulation of multiple matrix metalloproteinase (Mmp) genes.
    Martinez C; Bhattacharya S; Freeman T; Churchman M; Ilyas M
    J Pathol; 2005 May; 206(1):100-10. PubMed ID: 15809971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncated mouse adenomatous polyposis coli reduces connexin32 content and increases matrilysin secretion from Paneth cells.
    Husøy T; Ølstørn HB; Knutsen HK; Løberg EM; Cruciani V; Mikalsen SO; Goverud IL; Alexander J
    Eur J Cancer; 2004 Jul; 40(10):1599-603. PubMed ID: 15196546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.